| Current Price | $475.17 | Mkt Cap | $49.5B |
|---|---|---|---|
| Open | $476.22 | P/E Ratio | 14.55 |
| Prev. Close | $475.17 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $471.50 - $480.26 | Volume | 679,574 |
| 52-Wk Range | $441.00 - $664.64 | Avg. Daily Vol. | 1,004,826 |
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
| Current Price | $475.17 | Mkt Cap | $49.5B |
|---|---|---|---|
| Open | $476.22 | P/E Ratio | 14.55 |
| Prev. Close | $475.17 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $471.50 - $480.26 | Volume | 679,574 |
| 52-Wk Range | $441.00 - $664.64 | Avg. Daily Vol. | 1,004,826 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong coronavirus therapeutics portfolio and rapid revenue growth from oncology and opthamology projects.
$9.7B? Lots of obstacles, including Lucentis, Avastin, payers, etc., and the market is acting like they've already hit huge numbers. Strange self-limiting value prop on this, they had to develop it based on decreased injection frequency rather than… More
Read the most recent pitches from players about REGN.
Recs
Etirado
(43.96)
Submitted: 2/19/2021 10:10:18 AM :
Start Price:
$480.22
NASDAQ:REGN Score:
-6.13
Screener Pick 2-18-21
Recs
TMFjbonefish
(43.33)
Submitted: 12/16/2020 6:46:57 PM :
Start Price:
$486.90
NASDAQ:REGN Score:
-13.04
Innovative products and great culture are a winning combination over the long term.
Recs
TMFacarchidi
(< 20)
Submitted: 11/11/2020 3:47:43 PM :
Start Price:
$563.98
NASDAQ:REGN Score:
-31.10
Strong coronavirus therapeutics portfolio and rapid revenue growth from oncology and opthamology projects.
Find the members with the highest scoring picks in REGN.
oneisthelonelies (< 20) Score: +3,057.71
The Score Leader is the player with the highest score across all their picks in REGN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| oneisthelonelies | < 20 | 8/6/2007 |
|
5Y | $14.15 | +3,258.09% | +200.38% | +3,057.71 | 0 Comment | |
| DNAdivaSTL | 31.57 | 7/8/2008 |
|
NS | $14.30 | +3,222.87% | +239.52% | +2,983.35 | 0 Comment | |
| Grinnell4Eva | 41.49 | 6/6/2008 |
|
1Y | $14.88 | +3,093.35% | +212.03% | +2,881.31 | 0 Comment | |
| stlb1ues | 50.28 | 6/26/2008 |
|
1Y | $14.96 | +3,076.27% | +225.19% | +2,851.08 | 0 Comment | |
| kiranmn | < 20 | 5/27/2009 |
|
3Y | $14.49 | +3,179.30% | +354.73% | +2,824.57 | 0 Comment | |
| giffman62 | < 20 | 6/6/2008 |
|
NS | $15.22 | +3,022.01% | +203.92% | +2,818.09 | 1 Comment | |
| Pmccorm | 93.73 | 6/5/2008 |
|
3Y | $15.28 | +3,009.75% | +205.62% | +2,804.13 | 0 Comment | |
| benes27 | 71.85 | 6/5/2008 |
|
3M | $15.28 | +3,009.75% | +205.69% | +2,804.07 | 0 Comment | |
| UncleSmitty | 45.78 | 7/14/2008 |
|
NS | $15.24 | +3,017.91% | +238.63% | +2,779.29 | 0 Comment | |
| danbeachler | 88.41 |
|
|
5Y | $15.34 | +2,997.59% | +227.73% | +2,769.85 | 3 Comments |
See what the Wall Street professionals think, according to their public statements and filings.
